Press Releases

Month Year

Month Year

May 15, 2005

Taxotere® Regimen Demonstrates Significant Survival Benefit In The Treatment Of Advanced Gastric Cancer
May 13, 2005

Sanofi-aventis 2005 first-quarter net sales
May 10, 2005

Rescheduling of the pre-trial order date in the United States Plavix® litigation
May 10, 2005

New Eloxatin® and Taxotere® research to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO)
Apr 15, 2005

Sanofi-aventis affirms its commitment to Access to Medicines in the "Southern countries", with a policy of tiered drug prices geared to populations incomes
Apr 11, 2005

FDA issues approvable letter for AMBIEN CR™ (zolpidem tartrate extended release) C IV for the treatment of Insomnia
Apr 7, 2005

Sanofi-aventis Statement
Apr 1, 2005

Sanofi-aventis concludes €10 billion in medium-term credit agreements with its banks to refinance the Aventis acquisition financing entered into in April 2004
Mar 30, 2005

Rescheduling of the pre-trial order date in the United States Plavix® litigation
Mar 24, 2005

Sanofi-aventis joins the fight against tuberculosis in South Africa

Show per page

Print
Email page
RSS